naringenin and Astrocytoma, Grade IV

naringenin has been researched along with Astrocytoma, Grade IV in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's4 (66.67)2.80

Authors

AuthorsStudies
Banu Doğanlar, Z; Doğanlar, O; Kurtdere, K; Özcan, H; Zaim, Ö; Zreigh, MM1
Almaimani, RA; Almasmoum, HA; Alrobaian, M; Baothman, AA; Beg, S; Choudhry, H; Ghaith, MM; Ibrahim, IAA; Panda, SK; Shen, L; Singh, T; Wang, L; Wang, X1
Amirkhosravi, A; Juybari, KB; Mehrabani, M; Mehrbani, M; Mirzamohammdi, S; Nematollahi, MH; Sargazi, ML; Tarzi, ME1
Gabrani, R; Gautam, M1
Podgórski, R; Stompor, M; Uram, Ł1
Chang, YM; Chen, CJ; Chen, KM; Chen, PN; Chen, YY; Hseu, YC; Hsu, LS; Wang, KY; Yeh, KT1

Other Studies

6 other study(ies) available for naringenin and Astrocytoma, Grade IV

ArticleYear
Novel synthesis naringenin-benzyl piperazine derivatives prevent glioblastoma invasion by inhibiting the hypoxia-induced IL6/JAK2/STAT3 axis and activating caspase-dependent apoptosis.
    Bioorganic chemistry, 2022, Volume: 129

    Topics: Apoptosis; Cell Line, Tumor; Glioblastoma; Humans; Hypoxia; Interleukin-6; Janus Kinase 2; Piperazines; STAT3 Transcription Factor

2022
Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 138

    Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; Estrogen Antagonists; Female; Flavanones; Glioblastoma; Lipids; Male; Nanoparticles; Paclitaxel; Particle Size; Peptides, Cyclic; Rats; Rats, Wistar

2021
Naringenin attenuates cell viability and migration of C6 glioblastoma cell line: a possible role of hedgehog signaling pathway.
    Molecular biology reports, 2021, Volume: 48, Issue:9

    Topics: 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Flavanones; Glioblastoma; Mice; Rats; Repressor Proteins; Signal Transduction; Smoothened Receptor; Zinc Finger Protein GLI1

2021
Combinatorial Effect of Temozolomide and Naringenin in Human Glioblastoma Multiforme Cell Lines.
    Nutrition and cancer, 2022, Volume: 74, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Flavanones; Glioblastoma; Humans; Temozolomide

2022
In Vitro Effect of 8-Prenylnaringenin and Naringenin on Fibroblasts and Glioblastoma Cells-Cellular Accumulation and Cytotoxicity.
    Molecules (Basel, Switzerland), 2017, Jun-30, Volume: 22, Issue:7

    Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Fibroblasts; Flavanones; Glioblastoma; Humans; Molecular Structure

2017
Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms.
    Environmental toxicology, 2019, Volume: 34, Issue:3

    Topics: Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Flavanones; Glioblastoma; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness

2019